Cargando…
Severity and disease control before house dust mite immunotherapy initiation: ANTARES a French observational survey
BACKGROUND: Allergen immunotherapy (AIT) may be prescribed for patients with allergic rhinitis (AR) induced by house dust mites (HDM) whether asthma is present or not. Current guidelines provide insufficient support for therapeutic management strategy of these patients. Allergists however have long-...
Autores principales: | Demoly, Pascal, Broué-Chabbert, Anne, Wessel, François, Chartier, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827229/ https://www.ncbi.nlm.nih.gov/pubmed/27069487 http://dx.doi.org/10.1186/s13223-016-0119-z |
Ejemplares similares
-
The SQ HDM SLIT‐Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A “real‐life” French study
por: Demoly, Pascal, et al.
Publicado: (2022) -
Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017) -
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014) -
Worsening of chronic house-dust-mite-induced respiratory allergies: An observational survey in three European countries()
por: Demoly, Pascal, et al.
Publicado: (2021) -
New approaches to immunotherapy in house dust mite allergy
por: Kim, In Sik
Publicado: (2022)